| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/21/2001 | US6277357 Ketotricyclo[5.2.1.0]decane derivatives |
| 08/21/2001 | US6277061 Method of inhibiting membrane-type matrix metalloproteinase |
| 08/21/2001 | US6276533 Weight-specific elixir dosage calculation reference |
| 08/21/2001 | CA2319308C Pharmaceutical agents |
| 08/21/2001 | CA2294595C Inhibiting bone resorption |
| 08/21/2001 | CA2288407C Parathyroid hypertensive factor |
| 08/21/2001 | CA2207348C Benzimidazole derivatives |
| 08/21/2001 | CA2205555C Use of nitric oxide-releasing agents for reducing metastasis risk |
| 08/21/2001 | CA2196845C Hydroxamic acid compounds |
| 08/21/2001 | CA2184871C Anticonvulsive 1-ar(alk)ylimidazolin-2-ones, and process for making |
| 08/21/2001 | CA2174315C Oligonucleotide modulation of multidrug resistance-associated protein |
| 08/21/2001 | CA2100868C Derivatives of dicarboxylic acids having six to twelve carbon atoms and use of these derivatives and dicarboxylic acids alone in the preparation of pharmaceutical compositions forenteral and parenteral nutrition |
| 08/21/2001 | CA2094012C 1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents |
| 08/21/2001 | CA2093793C Alkylidene analogs of 1'-aminospiro¬isoquinoline-4(1h),-3'-pyrrolidine|1,2',3,5'(2h)-tetrones useful as aldose reductase inhibitors |
| 08/21/2001 | CA2083606C Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use |
| 08/21/2001 | CA2060652C N-substituted cycloalkyl and polycycloalkyl alpha-substituted trp-phe- and phenethylamine derivatives |
| 08/21/2001 | CA2054203C Macrolides for the treatment of reversible obstructive air-ways diseases |
| 08/21/2001 | CA2039855C Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases |
| 08/21/2001 | CA2026143C Triazole compounds, their production and use |
| 08/21/2001 | CA2018751C Stable freeze dried polyhematoporphyrin ether/ester composition |
| 08/21/2001 | CA2013324C Pteridin-4(3h)-ones, process for their preparation and drugs containing them |
| 08/21/2001 | CA2012955C Antitumor substance be-13793c |
| 08/18/2001 | CA2337786A1 New derivatives of phosphonic 6-sulfamoyl-3-quinolyl acids, the process for the preparation thereof and the pharmaceutical compounds containing them |
| 08/18/2001 | CA2337785A1 New derivatives of phosphonic 6-amino or 6-hydrazinosulfonyl-3-quinolinyl acids, the process for the preparation thereof and the pharmaceutical compounds containing them |
| 08/18/2001 | CA2337301A1 New quinolinyl phosphonic aryl or heteroaryl acid derivatives, their preparation process and the pharmaceutical compositions containing same |
| 08/16/2001 | WO2001059152A2 Polymorphisms in the human cyp2b6 gene and their use in diagnostic and therapeutic applications |
| 08/16/2001 | WO2001059137A1 Method for remodelling cell wall polysaccharide structures in plants |
| 08/16/2001 | WO2001059129A2 Mammalian secreted group iii phospholipase a2 |
| 08/16/2001 | WO2001059128A2 Novel elongase gene and method for producing multiple-unsaturated fatty acids |
| 08/16/2001 | WO2001059126A2 Gene cluster encoding a nystatin polyketide synthase and its manipulation and utility |
| 08/16/2001 | WO2001059120A2 Il-17 like molecules and uses thereof |
| 08/16/2001 | WO2001059104A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | WO2001059103A2 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | WO2001059102A2 Nucleozymes with endonuclease activity |
| 08/16/2001 | WO2001059100A2 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | WO2001059088A2 Vector |
| 08/16/2001 | WO2001059072A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 08/16/2001 | WO2001059071A2 Methods of preparing and using a viral vector library |
| 08/16/2001 | WO2001059067A2 A group of anti-cancer compounds with specific structure and their production method |
| 08/16/2001 | WO2001058954A2 Trade molecules and uses related thereto |
| 08/16/2001 | WO2001058951A2 Water-soluble ligand-binding proteins of ligand-gated ion channels, crystals thereof and their use for screening ligands of ligand-gated ion channels |
| 08/16/2001 | WO2001058945A1 Dna encoding human vanilloid receptor vr3 |
| 08/16/2001 | WO2001058936A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/16/2001 | WO2001058927A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 08/16/2001 | WO2001058921A2 Methods and compositions for generating angiostatin |
| 08/16/2001 | WO2001058918A2 Oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments |
| 08/16/2001 | WO2001058916A2 Antibodies to ccr5 |
| 08/16/2001 | WO2001058915A2 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/16/2001 | WO2001058907A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058906A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058902A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity |
| 08/16/2001 | WO2001058901A1 Pyrrolopyridazine compound |
| 08/16/2001 | WO2001058900A1 1h-imidazopyridine derivatives |
| 08/16/2001 | WO2001058899A1 Pyridine derivatives inhibiting angiogenesis and/or vegf receptor tyrosine kinase |
| 08/16/2001 | WO2001058898A1 Preventive or therapeutic agents for gastric or esophageal regurgitation |
| 08/16/2001 | WO2001058897A1 Benzthiazoles as tnf and pde-iv inhibitors |
| 08/16/2001 | WO2001058896A1 Benzoxazole derivatives as tnf and pde iv inhibitors |
| 08/16/2001 | WO2001058895A1 Benzofuran carboxamides and their therapeutic use |
| 08/16/2001 | WO2001058893A2 Indol-3-yl derivatives and their use as integrin inhibitors |
| 08/16/2001 | WO2001058892A1 Tyrosine derivatives with anti-leukotriene activity |
| 08/16/2001 | WO2001058891A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 08/16/2001 | WO2001058890A1 Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2 |
| 08/16/2001 | WO2001058889A1 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 08/16/2001 | WO2001058888A1 A sesquiterpenoic compound and pharmaceutical formulations comprising the same |
| 08/16/2001 | WO2001058886A1 Dipeptide nitrile cathepsin k inhibitors |
| 08/16/2001 | WO2001058885A1 Oxazolidinone thioamides with piperazine amide substituents |
| 08/16/2001 | WO2001058882A1 Use of pyrimidine endothelin antagonists in companion animals |
| 08/16/2001 | WO2001058881A1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 08/16/2001 | WO2001058880A1 Novel triazole derivatives |
| 08/16/2001 | WO2001058879A1 2-phenylcarbamoyl-benzimidazoles |
| 08/16/2001 | WO2001058878A1 2-carboxamide-benzimidazoles useful in the treatment and prevention of ischemic reperfusion injury |
| 08/16/2001 | WO2001058876A1 Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient |
| 08/16/2001 | WO2001058875A2 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives |
| 08/16/2001 | WO2001058869A2 Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases |
| 08/16/2001 | WO2001058866A2 Ocular hypotensive lipids |
| 08/16/2001 | WO2001058855A1 Use of androgen receptor suppressors |
| 08/16/2001 | WO2001058854A1 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 08/16/2001 | WO2001058853A1 Dehydroamino acids |
| 08/16/2001 | WO2001058852A2 (r)-2-aryl-propionamides, useful in the inhibition of il-8-induced chemiotaxis of neutrophils |
| 08/16/2001 | WO2001058849A1 SURFACE ACTIVE AGENTS DERIVED FROM 1-O-Nα-ACETYL-L-AMINOACYL ESTER 3-O-MONOACYL GLYCERIDES AND 1-O-Nα-ACETYL L-AMINOACYL ESTER 2,3-O-DIACYL GLYCERIDES TYPE AMINO ACIDS AND THE PREPARATION THEREOF |
| 08/16/2001 | WO2001058514A1 Drug delivery apparatus |
| 08/16/2001 | WO2001058491A1 Drug comprising combination |
| 08/16/2001 | WO2001058490A1 Liver-selective chemotherapy |
| 08/16/2001 | WO2001058489A1 Preventives/remedies for postoperative stress |
| 08/16/2001 | WO2001058488A1 Remedies for sjoegren's syndrome |
| 08/16/2001 | WO2001058487A1 Therapeutic and/or preventive agents for optic nerve diseases and retinal diseases |
| 08/16/2001 | WO2001058476A2 Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity |
| 08/16/2001 | WO2001058471A2 Novel amino acid and peptide inhibitors of staphylococcus virulence |
| 08/16/2001 | WO2001058470A2 Methods for enhancing the bioavailability of a drug |
| 08/16/2001 | WO2001058469A1 Methods for treating glaucoma |
| 08/16/2001 | WO2001058464A1 Water dispersed ivermectin dosage form used for curing ecto- and endoparasitic diseases |
| 08/16/2001 | WO2001058459A1 Remedies for hepatitis c |
| 08/16/2001 | WO2001058457A1 Novel uses of polyanionic polyglycosides in treating gut disorders |
| 08/16/2001 | WO2001058456A1 Polyanionic polyglycosides in the treatment of autism |
| 08/16/2001 | WO2001058455A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| 08/16/2001 | WO2001058454A1 Compounds useful for the treatment or prevention of a disease mediated by the alpha-2b-adrenoceptor |
| 08/16/2001 | WO2001058453A1 The use of mirtazapine for the treatment of sleep disorders |
| 08/16/2001 | WO2001058452A1 Thermal ablation of tissue |
| 08/16/2001 | WO2001058451A1 Tamper-resistant oral opioid agonist formulations |
| 08/16/2001 | WO2001058450A2 Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation |